Last reviewed · How we verify

NCT05318313

Telerehabilitation for TMD

Completed Last updated 6 January 2026
What this trial tests

trial testing Telerehabilitation in Temporomandibular Disorder in 207 participants. Completed in 1 July 2024.

Timeline
17 June 2022
Primary endpoint
1 July 2024
1 July 2024

Quick facts

Lead sponsorUniversity of Minnesota
StatusCompleted
Study typeOBSERVATIONAL
Enrollment207
Start date17 June 2022
Primary completion1 July 2024
Estimated completion1 July 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Minnesota

Who can join

Adults 18 to 70, any sex, with Temporomandibular Disorder or TMJ Disc Displacement With Reduction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therapy via telerehabilitation is as good as standard in-person care for these individuals. Long term outcomes including patient satisfaction, cost-effectiveness analysis, and functional status will describe the feasibility of telerehabilitation as a management intervention for this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Telerehabilitation

Trials testing the same drug.

Other recruiting trials for Temporomandibular Disorder

Currently open trials in the same condition.

Other University of Minnesota trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318313.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing